Amarantus Bioscience Holdings Inc (AMBS)

[sumotrader]

With the current fundamentals and a market cap of only $69 million AMBS is THE MOST UNDERVALUED stock on the OTC today.

Regardless of where the PPS goes in the next couple weeks AMBS will recover to .20 near term. A PROPORTIONAL R/S at that level would put the PPS at $2.00-$4.00 while reducing the A/S back down to 200 million or even 100 million. Why is anyone concerned about a short term increase in A/S when it creates ABSOLUTELY NO MORE opportunity for dilution??? It is completely unnecessary given that AMBS has $18 million in financing with the current share structure to carry it into 2016.

It all comes down to the uplist now IMO, if it comes before before January 2015 we are in a strong position (as per Gerald's blog) and if it is postponed then we have reason to be concerned. Why put the cart before the horse when fundamentals continue to improve and milestones continue to be met???

Progress happens on FDA timelines, not "I need huge profits yesterday" timelines.

The patient and well informed will get the last laugh here.

GO AMBS